Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) shot up 3.9% during trading on Wednesday . The company traded as high as $0.2850 and last traded at $0.2910. 400 shares were traded during trading, a decline of 98% from the average session volume of 17,458 shares. The stock had previously closed at $0.28.
Alpha Tau Medical Stock Performance
The business has a 50-day moving average price of $0.33 and a 200 day moving average price of $0.27.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Read More
- Five stocks we like better than Alpha Tau Medical
- Roth IRA Calculator: Calculate Your Potential Returns
- Rare Earth Stocks: The Truce That Isn’t a Truce
- How to Use the MarketBeat Excel Dividend Calculator
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- What Are Growth Stocks and Investing in Them
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
